STOCK TITAN

ALPS Medical Breakthroughs ETF Stock Price, News & Analysis

SBIO NYSE

Company Description

ALPS Medical Breakthroughs ETF (NYSE: SBIO) is a publicly traded company.

SBIO stock has gained 90.8% over the past year. Shares last traded at $54.42.

This page provides a comprehensive overview of SBIO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$54.28
-0.57%
0.31
Last updated: April 24, 2026 at 16:00
+90.85%
Performance 1 year

ALPS Medical Breakthroughs ETF (SBIO) stock last traded at $54.42, down 0.57% from the previous close. Over the past 12 months, the stock has gained 90.8%.

Latest News

ALPS Medical Breakthroughs ETF has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all SBIO news →

SEC Filings

No SEC filings available for SBIO.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in ALPS Medical Breakthroughs ETF (SBIO) currently stands at 4.1 thousand shares, down 18.7% from the previous reporting period, representing 0.2% of the float. Over the past 12 months, short interest has increased by 15.8%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for ALPS Medical Breakthroughs ETF (SBIO) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.9 days.

Frequently Asked Questions

What is the current stock price of ALPS Medical Breakthroughs ETF (SBIO)?

The current stock price of ALPS Medical Breakthroughs ETF (SBIO) is $54.42 as of April 24, 2026.